| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.00075 | 1 |